Literature DB >> 8450791

Slow-release verapamil poisoning. Use of polyethylene glycol whole-bowel lavage and high-dose calcium.

N Buckley1, A H Dawson, D Howarth, I M Whyte.   

Abstract

OBJECTIVE: To present three cases of slow-release verapamil poisoning that demonstrate the prolonged absorption of the drug and the role of polyethylene glycol and high-dose calcium in management. CLINICAL FEATURES: Three patients with slow-release verapamil poisoning are presented. An 18-year-old woman took 2.3 g and developed hypotension and bradyarrhythmias 18 hours after ingestion, despite gastric lavage and administration of charcoal at three hours. A 23-year-old woman took 4.8 g and presented two hours later clinically unaffected. A 44-year-old woman presented 24 hours after taking 15-20 g. She had a systolic blood pressure of 50 mmHg, no measurable diastolic blood pressure and bradyarrhythmias. INTERVENTION AND OUTCOME: Case 1 responded to administration of 30 g of calcium and fluids intravenously. Case 2 was given polyethylene glycol on admission which resulted in passage of a tablet bezoar and no toxicity. Polyethylene glycol was ineffective in Case 3. She responded initially to high doses of calcium and other treatments, but subsequently died of hypotension and cardiac conduction block 39 hours after the overdose.
CONCLUSION: The severity of poisoning with slow-release verapamil warrants aggressive pre-emptive treatment. Polyethylene glycol should be used routinely irrespective of the clinical state. High doses of calcium may be required to treat conduction block and hypotension.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8450791

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  11 in total

1.  Comparative hemodynamic effects of levosimendan alone and in conjunction with 4-aminopyridine or calcium chloride in a rodent model of severe verapamil poisoning.

Authors:  Andis Graudins; Kathy Ka Ling Wong
Journal:  J Med Toxicol       Date:  2010-06

2.  Successful treatment of refractory hypotension, noncardiogenic pulmonary edema and acute kidney injury after an overdose of amlodipine.

Authors:  Vivek B Kute; Pankaj R Shah; Kamal R Goplani; Manoj R Gumber; A V Vanikar; Hargovind L Trivedi
Journal:  Indian J Crit Care Med       Date:  2011-07

Review 3.  Bezoars: implicated drugs and avoidance strategies.

Authors:  K C Thompson; J P Iredale
Journal:  Drug Saf       Date:  1996-02       Impact factor: 5.606

4.  Prolonged half-life of verapamil in a case of overdose: implications for therapy.

Authors:  C D Buckley; J K Aronson
Journal:  Br J Clin Pharmacol       Date:  1995-06       Impact factor: 4.335

5.  Overdose with calcium channel blockers.

Authors:  N A Buckley; I M Whyte; A H Dawson
Journal:  BMJ       Date:  1994-06-18

6.  A fatal case of iatrogenic hypercalcemia after calcium channel blocker overdose.

Authors:  Michael T Sim; Frazier T Stevenson
Journal:  J Med Toxicol       Date:  2008-03

7.  [Seizure and non-cardiogenic pulmonary edema after intoxication].

Authors:  M Sawatzki; O Kummer; S Krähenbühl; M Siegemund
Journal:  Internist (Berl)       Date:  2010-04       Impact factor: 0.743

Review 8.  Controlled release drugs in overdose. Clinical considerations.

Authors:  N A Buckley; A H Dawson; D A Reith
Journal:  Drug Saf       Date:  1995-01       Impact factor: 5.606

9.  Experts Consensus Recommendations for the Management of Calcium Channel Blocker Poisoning in Adults.

Authors:  Maude St-Onge; Kurt Anseeuw; Frank Lee Cantrell; Ian C Gilchrist; Philippe Hantson; Benoit Bailey; Valéry Lavergne; Sophie Gosselin; William Kerns; Martin Laliberté; Eric J Lavonas; David N Juurlink; John Muscedere; Chen-Chang Yang; Tasnim Sinuff; Michael Rieder; Bruno Mégarbane
Journal:  Crit Care Med       Date:  2017-03       Impact factor: 7.598

Review 10.  Treatment for calcium channel blocker poisoning: a systematic review.

Authors:  M St-Onge; P-A Dubé; S Gosselin; C Guimont; J Godwin; P M Archambault; J-M Chauny; A J Frenette; M Darveau; N Le Sage; J Poitras; J Provencher; D N Juurlink; R Blais
Journal:  Clin Toxicol (Phila)       Date:  2014-10-06       Impact factor: 4.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.